Austin, Texas – August 24, 2026 – The global predictive genetic testing and consumer genomics market is growing fast, and the next phase of that growth isn’t happening at the consumer level. According to Global Market Insights, the market was valued at $7.4 billion in 2024, is projected to reach $8.3 billion in 2025, and is on track to hit $27.1 billion by 2034, a 14% compound annual growth rate driven by rising demand for personalized healthcare and a broad shift toward preventive medicine. GeneMetrics, a white-label genetic testing platform, says that trajectory signals a clear inflection point for clinics, health professionals, and wellness brands: the patients asking about genetic testing aren’t waiting for consumer apps to catch up. They’re asking their providers.
Key Facts:
Global Market Insights values the predictive genetic testing and consumer genomics market at $7.4 billion in 2024, rising to a projected $8.3 billion in 2025 The market is projected to reach $27.1 billion by 2034, representing a 14% CAGR from 2025 to 2034 (Global Market Insights) Global Market Insights identifies increasing consumer interest in personalized healthcare, advances in genetic testing technologies, and a shift toward proactive preventive care as the primary growth drivers GeneMetrics enables licensed practitioners and wellness brands to launch fully branded genetic testing programs, including kit fulfillment, lab processing, bioinformatics, and report generation Standard white-label configurations on the GeneMetrics platform can launch in as little as 72 hours The platform supports customizable sequencing options, from targeted diagnostics to whole genome analysis, under the provider’s own brand The numbers are notable, but the more important signal is structural. The growth Global Market Insights describes isn’t being driven by people buying ancestry kits out of curiosity. It’s being driven by patients who want answers to real health questions and are starting to expect their providers to help them find those answers. That’s a different kind of demand, and it doesn’t resolve with a consumer app. It resolves at the point of care.
The challenge for most practitioners isn’t interest. It’s infrastructure. Building a genetic testing program from scratch means establishing lab relationships, managing kit logistics, commissioning bioinformatics pipelines, designing reports, and meeting HIPAA and GDPR compliance requirements before a single test reaches a patient. Most practices don’t have the resources to build that stack, and most don’t need to. GeneMetrics handles the entire back end, from sample collection kits bearing the provider’s brand to clinically-backed reports delivered under that same brand. The provider owns the patient relationship and the program. GeneMetrics handles everything behind it.
That model matters more as the market grows. A $27.1 billion market creates real competition for patient attention and loyalty, and the practices that build genetic programs now are the ones establishing that loyalty before the space gets crowded. The consumer genomics market is expanding alongside demand for personalized and preventive health approaches, and the providers positioned to meet that demand aren’t the ones still evaluating whether to add genetic testing. They’re the ones who already have it running.
For health tech companies and wellness brands working at scale, the platform supports national deployment. For solo practitioners or regional clinics testing the model, a standard configuration can be live in 72 hours. The sequencing scope is adjustable, meaning a practice can start with targeted panels and expand to whole genome analysis as patient volume and clinical scope grow. The infrastructure scales; the brand stays consistent throughout.
The market data gives a number. What it doesn’t capture is the cost of waiting until that number is fully realized. By 2034, this market will look very different from how it looks today. The practices building now will have years of patient data, refined workflows, and established programs. The ones who wait will be starting from scratch in a much more competitive environment.
About GeneMetrics
GeneMetrics provides white-label DNA testing solutions that allow health professionals, clinics, and wellness brands to offer fully branded genetic testing under their own name. The platform handles all logistics, lab processing, bioinformatics, and report generation, enabling practitioners to deliver personalized genetic insights to patients without building their own laboratory infrastructure. GeneMetrics is HIPAA and GDPR compliant, with multi-level encryption and a Beyond-White-Label model designed for providers who want to own their genetic program, not just resell someone else’s.
Media ContactCompany Name: GeneMetricsContact Person: Chris HaasEmail: Send EmailPhone: +1 (189) 820-2601City: AustinState: TexasCountry: United StatesWebsite: http://genemetrics.com/
